Aarti Drugs
18 May, 2024 18:20 BSE: 524348
NSE: AARTIDRUGSISIN: INE767A01016
Start SIP in Aarti Drugs
Start SIPAarti Drugs Performance
Day Range
- Low 487
- High 493
52 Week Range
- Low 431
- High 646
- Open Price493
- Previous Close491
- Volume9093
Aarti Drugs Financials
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 560 | 538 | 578 | 592 | 696 |
Operating Expenses Qtr Cr | 490 | 478 | 512 | 520 | 608 |
Operating Profit Qtr Cr | 69 | 60 | 65 | 72 | 89 |
Depreciation Qtr Cr | 12 | 12 | 12 | 12 | 12 |
Interest Qtr Cr | 8 | 7 | 8 | 8 | 8 |
Tax Qtr Cr | 14 | 11 | 12 | 14 | 16 |
Net Profit Qtr Cr | 36 | 32 | 35 | 40 | 53 |
Aarti Drugs Technicals
EMA & SMA
Current Price
₹487.8
-2.75 (-0.56%)
- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- ₹484.16
- 50 Day
- ₹487.27
- 100 Day
- ₹492.79
- 200 Day
- ₹493.91
- 20 Day
- ₹488.15
- 50 Day
- ₹478.38
- 100 Day
- ₹498.59
- 200 Day
- ₹513.70
Aarti Drugs Resistance and Support
PIVOT
₹489.05
Resistance | |
---|---|
First Resistance | 491.50 |
Second Resistance | 495.20 |
Third Resistance | 497.65 |
RSI | 51.91 |
MFI | 29.90 |
MACD Single Line | -1.69 |
MACD | -1.63 |
Support | |
---|---|
First Support | 485.35 |
Second Support | 482.90 |
Third Supoort | 479.20 |
Aarti Drugs Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 9,341 | 630,424 | 67.49 |
Week | 65,046 | 2,890,629 | 44.44 |
1 Month | 107,143 | 4,547,163 | 42.44 |
6 Month | 302,434 | 11,927,985 | 39.44 |
Aarti Drugs Result Highlights
Aarti Drugs Synopsis
NSE-Medical-Diversified
Aarti Drugs Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 2266.91 Cr. and Equity Capital is Rs. 91.94 Cr. for the Year ended 31/03/2024. Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433.Market Cap | 4,510 |
Sales | 2,267 |
Shares in Float | 3.95 |
No of funds | 85 |
Yield | 0.21 |
Book Value | 3.84 |
U/D Vol ratio | 0.9 |
LTDebt / Equity | 20 |
Alpha | -0.08 |
Beta | 0.97 |
Aarti Drugs Shareholding Pattern
Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
---|---|---|---|---|
Promoters | 57.13% | 57.47% | 58.56% | 58.7% |
Mutual Funds | 5.08% | 5.18% | 5.22% | 4.63% |
Insurance Companies | 0.08% | 0.08% | 0.1% | 0.08% |
Foreign Portfolio Investors | 2.56% | 2.1% | 2.33% | 1.97% |
Financial Institutions/ Banks | ||||
Individual Investors | 25.12% | 25.84% | 24.65% | 25.35% |
Others | 10.03% | 9.33% | 9.14% | 9.27% |
Aarti Drugs Management
Name | Designation |
---|---|
Mr. Chandrakant V Gogri | Chairman Emeritus |
Mr. Prakash M Patil | Chairman & M.D & CEO |
Mr. Rashesh C Gogri | Managing Director |
Mr. Harshit M Savla | Joint Managing Director |
Mr. Harit P Shah | Executive Director |
Mr. Uday M Patil | Executive Director |
Mrs. Neha R Gada | Independent Director |
CA. Navin C Shah | Independent Director |
Dr. Krishnacharya G Akamanchi | Independent Director |
Prof. Bhaskar N Thorat | Independent Director |
Mrs. Priti P Savla | Independent Director |
Mr. Ankit V Paleja | Independent Director |
Mr. Narendra J Salvi | Non Executive Director |
Aarti Drugs Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Aarti Drugs Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-05-03 | Audited Results | |
2024-01-24 | Quarterly Results & Interim Dividend | |
2023-10-19 | Quarterly Results | |
2023-07-21 | Quarterly Results & Buy Back | |
2023-04-29 | Audited Results |
Date | Purpose | Remarks |
---|---|---|
2024-02-06 | INTERIM | Rs.1.00 per share(10%)Interim Dividend |
2023-02-08 | INTERIM | Rs.1.00 per share(10%)Interim Dividend |
2022-02-10 | INTERIM | Rs.1.00 per share(10%)Interim Dividend |
Aarti Drugs FAQs
What is Share Price of Aarti Drugs ?
Aarti Drugs share price is ₹487 As on 18 May, 2024 | 18:06
What is the Market Cap of Aarti Drugs ?
The Market Cap of Aarti Drugs is ₹4484.6 Cr As on 18 May, 2024 | 18:06
What is the P/E ratio of Aarti Drugs ?
The P/E ratio of Aarti Drugs is 26.2 As on 18 May, 2024 | 18:06
What is the PB ratio of Aarti Drugs ?
The PB ratio of Aarti Drugs is 3.5 As on 18 May, 2024 | 18:06